Skip to main content

Flexion Therapeutics Inc

FLXNDelisted Nov 19, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0001419600

Flexion Therapeutics Inc was delisted on Nov 19, 2021; its insiders filed their last Form 4 on Nov 23, 2021; 145 institutions reported holding it in 13F filings for Q3 2021, worth $230.4M in total; no superinvestor held it.

Holders of 5% or more of FLXN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Flexion Therapeutics Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Flexion Therapeutics Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

10 Schedule 13D and 13G filings on Flexion Therapeutics Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on FLXN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 24, 2021Newtyn Management, LLC13GOld format–New–SEC
Nov 9, 2021Wasatch Advisors Inc13G/AOld format–––SEC
May 10, 2021Miller Value Partners, LLC13G/AOld format–––SEC
Feb 16, 2021Capital World Investors13G/AOld format–––SEC
Feb 16, 2021Miller Value Partners, LLC13G/AOld format–––SEC
Feb 11, 2021Wasatch Advisors Inc13G/AOld format–––SEC
Feb 10, 2021Artisan Partners Limited Partnership13GOld format–New–SEC
Feb 10, 2021State Street Corp13GOld format–New–SEC
Jan 29, 20219:57 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 26, 2021Versant Venture Capital III, L.P.13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Flexion Therapeutics Inc shares.

No Form 144 notices for Flexion Therapeutics Inc are on file.